Cetera Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$9.56M Buy
16,453
+6,327
+62% +$3.68M 0.08% 261
2023
Q4
$5.37M Buy
10,126
+714
+8% +$379K 0.07% 253
2023
Q3
$4.76M Buy
9,412
+309
+3% +$156K 0.07% 257
2023
Q2
$4.75M Sell
9,103
-476
-5% -$248K 0.07% 248
2023
Q1
$5.52M Buy
9,579
+262
+3% +$151K 0.09% 230
2022
Q4
$5.13M Buy
9,317
+2,723
+41% +$1.5M 0.09% 228
2022
Q3
$3.34M Buy
6,594
+280
+4% +$142K 0.09% 244
2022
Q2
$3.43M Buy
6,314
+941
+18% +$511K 0.08% 264
2022
Q1
$3.17M Sell
5,373
-35
-0.6% -$20.7K 0.06% 311
2021
Q4
$3.61M Sell
5,408
-105
-2% -$70.1K 0.07% 270
2021
Q3
$3.15M Buy
5,513
+151
+3% +$86.3K 0.06% 305
2021
Q2
$2.71M Buy
5,362
+516
+11% +$260K 0.06% 299
2021
Q1
$2.21M Buy
4,846
+334
+7% +$152K 0.06% 300
2020
Q4
$2.1M Buy
4,512
+660
+17% +$307K 0.07% 266
2020
Q3
$1.7M Buy
3,852
+469
+14% +$207K 0.06% 274
2020
Q2
$1.23M Buy
3,383
+933
+38% +$338K 0.05% 315
2020
Q1
$695K Buy
2,450
+975
+66% +$277K 0.04% 387
2019
Q4
$478K Buy
1,475
+27
+2% +$8.75K 0.02% 580
2019
Q3
$422K Buy
1,448
+67
+5% +$19.5K 0.02% 596
2019
Q2
$404K Buy
1,381
+225
+19% +$65.8K 0.02% 619
2019
Q1
$312K Sell
1,156
-183
-14% -$49.4K 0.02% 632
2018
Q4
$299K Buy
1,339
+236
+21% +$52.7K 0.02% 627
2018
Q3
$272K Sell
1,103
-3,423
-76% -$844K 0.01% 767
2018
Q2
$934K Buy
4,526
+104
+2% +$21.5K 0.05% 339
2018
Q1
$910K Buy
+4,422
New +$910K 0.05% 329
2017
Q2
Sell
-1,634
Closed -$254K 856
2017
Q1
$254K Buy
+1,634
New +$254K 0.02% 630